245 related articles for article (PubMed ID: 30026863)
1. HUWE1 controls the development of non-small cell lung cancer through down-regulation of p53.
Yang D; Cheng D; Tu Q; Yang H; Sun B; Yan L; Dai H; Luo J; Mao B; Cao Y; Yu X; Jiang H; Zhao X
Theranostics; 2018; 8(13):3517-3529. PubMed ID: 30026863
[TBL] [Abstract][Full Text] [Related]
2. LIMCH1 suppress the growth of lung cancer by interacting with HUWE1 to sustain p53 stability.
Zhang Y; Zhang Y; Xu H
Gene; 2019 Sep; 712():143963. PubMed ID: 31279706
[TBL] [Abstract][Full Text] [Related]
3. A network of substrates of the E3 ubiquitin ligases MDM2 and HUWE1 control apoptosis independently of p53.
Kurokawa M; Kim J; Geradts J; Matsuura K; Liu L; Ran X; Xia W; Ribar TJ; Henao R; Dewhirst MW; Kim WJ; Lucas JE; Wang S; Spector NL; Kornbluth S
Sci Signal; 2013 May; 6(274):ra32. PubMed ID: 23652204
[TBL] [Abstract][Full Text] [Related]
4. Tumour suppressive function of HUWE1 in thyroid cancer.
Ma W; Zhao P; Zang L; Zhang K; Liao H; Hu Z
J Biosci; 2016 Sep; 41(3):395-405. PubMed ID: 27581931
[TBL] [Abstract][Full Text] [Related]
5. DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.
Wu DW; Lee MC; Wang J; Chen CY; Cheng YW; Lee H
Oncogene; 2014 Mar; 33(12):1515-26. PubMed ID: 23584477
[TBL] [Abstract][Full Text] [Related]
6. Differential response between the p53 ubiquitin-protein ligases Pirh2 and MdM2 following DNA damage in human cancer cells.
Duan W; Gao L; Wu X; Zhang Y; Otterson GA; Villalona-Calero MA
Exp Cell Res; 2006 Oct; 312(17):3370-8. PubMed ID: 16934800
[TBL] [Abstract][Full Text] [Related]
7. Targeting of the E3 ubiquitin-protein ligase HUWE1 impairs DNA repair capacity and tumor growth in preclinical multiple myeloma models.
Kunz V; Bommert KS; Kruk J; Schwinning D; Chatterjee M; Stühmer T; Bargou R; Bommert K
Sci Rep; 2020 Oct; 10(1):18419. PubMed ID: 33116152
[TBL] [Abstract][Full Text] [Related]
8. Huwe1 Sustains Normal Ovarian Epithelial Cell Transformation and Tumor Growth through the Histone H1.3-
Yang D; Sun B; Zhang X; Cheng D; Yu X; Yan L; Li L; An S; Jiang H; Lasorella A; Iavarone A; Zhang S; Zou F; Zhao X
Cancer Res; 2017 Sep; 77(18):4773-4784. PubMed ID: 28687618
[TBL] [Abstract][Full Text] [Related]
9. CRL4B
Liu F; Cao L; Zhang T; Chang F; Xu Y; Li Q; Deng J; Li L; Shao G
Biochem Biophys Res Commun; 2018 Jun; 501(2):440-447. PubMed ID: 29738775
[TBL] [Abstract][Full Text] [Related]
10. DNA damage-induced activation of CUL4B targets HUWE1 for proteasomal degradation.
Yi J; Lu G; Li L; Wang X; Cao L; Lin M; Zhang S; Shao G
Nucleic Acids Res; 2015 May; 43(9):4579-90. PubMed ID: 25883150
[TBL] [Abstract][Full Text] [Related]
11. Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.
Fortunato O; Boeri M; Moro M; Verri C; Mensah M; Conte D; Caleca L; Roz L; Pastorino U; Sozzi G
Cell Death Dis; 2014 Dec; 5(12):e1564. PubMed ID: 25501825
[TBL] [Abstract][Full Text] [Related]
12. Inverse association between MDM2 and HUWE1 protein expression levels in human breast cancer and liposarcoma.
Canfield K; Wells W; Geradts J; Kinlaw WB; Cheng C; Kurokawa M
Int J Clin Exp Pathol; 2016; 9(6):6342-6349. PubMed ID: 29375730
[TBL] [Abstract][Full Text] [Related]
13. HUWE1 upregulation has tumor suppressive effect in human prostate cancer cell lines through c-Myc.
Qu H; Liu H; Jin Y; Cui Z; Han G
Biomed Pharmacother; 2018 Oct; 106():309-315. PubMed ID: 29966975
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitination by HUWE1 in tumorigenesis and beyond.
Kao SH; Wu HT; Wu KJ
J Biomed Sci; 2018 Sep; 25(1):67. PubMed ID: 30176860
[TBL] [Abstract][Full Text] [Related]
15. TRIM65 negatively regulates p53 through ubiquitination.
Li Y; Ma C; Zhou T; Liu Y; Sun L; Yu Z
Biochem Biophys Res Commun; 2016 Apr; 473(1):278-282. PubMed ID: 27012201
[TBL] [Abstract][Full Text] [Related]
16. Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma.
Bonazzoli E; Bellone S; Zammataro L; Gnutti B; Guglielmi A; Pelligra S; Nagarkatti N; Manara P; Tymon-Rosario J; Zeybek B; Altwerger G; Menderes G; Han C; Ratner E; Silasi DA; Huang GS; Andikyan V; Azodi M; Schwartz PE; Santin AD
Gynecol Oncol; 2020 Sep; 158(3):769-775. PubMed ID: 32600791
[TBL] [Abstract][Full Text] [Related]
17. ATG101 Degradation by HUWE1-Mediated Ubiquitination Impairs Autophagy and Reduces Survival in Cancer Cells.
Lee J; Kim J; Shin J; Kang Y; Choi J; Cheong H
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502089
[TBL] [Abstract][Full Text] [Related]
18. A novel SNP in HUWE1 promoter confers increased risk of NOA by affecting the RA/RARα pathway in Chinese individuals.
Shan X; Zhang X; Huang G; Lv J; Ye Z; Jiang C; Jiang X; Cheng J; Lin H; Jiang H; Yue H; Wang Z; Xu W
Andrology; 2024 Feb; 12(2):338-348. PubMed ID: 37290064
[TBL] [Abstract][Full Text] [Related]
19. The E3 ligase HUWE1 mediates TGFBR2 ubiquitination and promotes gastric cancer cell proliferation, migration, and invasion.
He Y; Zhou J; Wan Q
Invest New Drugs; 2021 Jun; 39(3):713-723. PubMed ID: 33405091
[TBL] [Abstract][Full Text] [Related]
20. The structure and regulation of the E3 ubiquitin ligase HUWE1 and its biological functions in cancer.
Gong X; Du D; Deng Y; Zhou Y; Sun L; Yuan S
Invest New Drugs; 2020 Apr; 38(2):515-524. PubMed ID: 32008177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
